Suzetrigine: A Newly FDA-Approved Non-Opioid Treatment Option for Management of Moderate to Severe Acute Pain. (PubMed, Innov Clin Neurosci) - Sep 20, 2026 - "The recent United States Food and Drug Administration approval of suzetrigine introduces a novel class of analgesics; however, its clinical impact has yet to be defined."
FDA event • Journal • Review • Aesthetic Medicine • Constipation • Dermatology • Gastroenterology • Gastrointestinal Disorder • Pain • Pruritus
|
|
Alexandra R Rola; Emily E Leppien; Jared R Bagley
|